Actively Recruiting
Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
Led by Chang Gung Memorial Hospital · Updated on 2025-11-25
6266
Participants Needed
1
Research Sites
537 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.
CONDITIONS
Official Title
Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals (male or female) aged 20 years or older
- Willing and able to provide written informed consent to participate in the study
You will not qualify if you...
- Pregnant or breastfeeding women
- Patients with end-stage renal disease receiving hemodialysis or peritoneal dialysis
- Individuals currently undergoing active cancer treatment
- Recipients of any organ transplantation
- Patients diagnosed with dementia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chang Gung Memorial Hospitals, Linkou
Taoyuan, Taiwan
Actively Recruiting
Research Team
C
Chi-Hsiao Yeh, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here